Standout Papers

Conditionally replicating herpes simplex virus mutant, G207 for the t... 1991 2026 2002 2014 779
  1. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial (2000)
    James M. Markert, Michael D. Medlock et al. Gene Therapy
  2. Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant (1991)
    Robert L. Martuza, Amy Malick et al. Science

Immediate Impact

15 by Nobel laureates 28 from Science/Nature 67 standout
Sub-graph 1 of 23

Citing Papers

CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy
2023 Standout
A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma
2022 Standout
23 intermediate papers

Works of James M. Markert being referenced

Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM
2008
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
2000 Standout
and 13 more

Author Peers

Author Last Decade Papers Cites
James M. Markert 4328 2247 3387 3121 194 8.3k
Hiroaki Wakimoto 2811 1254 3669 4662 182 9.2k
Tomoki Todo 3273 1744 2757 3055 141 7.0k
Robert L. Martuza 5969 5290 4609 4876 173 13.1k
Juàn Fueyo 3162 698 3255 4445 160 6.9k
Evanthia Galanis 3485 2992 4554 4585 245 15.6k
Kenneth W. Culver 4339 1009 2214 4062 74 6.9k
Brenda L. Gallie 1545 934 6026 5964 248 12.6k
Claudio Bordignon 4671 1165 5764 5877 221 13.8k
Timothy P. Cripe 2226 1333 2085 2441 173 6.1k
David A. Largaespada 2593 507 1842 7666 212 11.6k

All Works

Loading papers...

Rankless by CCL
2026